These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32448615)

  • 21. Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment.
    Habič A; Novak M; Majc B; Lah Turnšek T; Breznik B
    J Histochem Cytochem; 2021 Dec; 69(12):775-794. PubMed ID: 34310223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications.
    Persano L; Rampazzo E; Della Puppa A; Pistollato F; Basso G
    ScientificWorldJournal; 2011; 11():1829-41. PubMed ID: 22125441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Stem Cell-Associated Immune Microenvironment in Recurrent Glioblastomas.
    Murota Y; Tabu K; Taga T
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graphene-Induced Transdifferentiation of Cancer Stem Cells as a Therapeutic Strategy against Glioblastoma.
    Martelli C; King A; Simon T; Giamas G
    ACS Biomater Sci Eng; 2020 Jun; 6(6):3258-3269. PubMed ID: 33463176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The extracellular matrix niche microenvironment of neural and cancer stem cells in the brain.
    Reinhard J; Brösicke N; Theocharidis U; Faissner A
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):174-183. PubMed ID: 27157088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.
    Daniele S; Zappelli E; Natali L; Martini C; Trincavelli ML
    Cell Death Dis; 2014 Nov; 5(11):e1539. PubMed ID: 25429616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Brain tumor stem cells].
    Hide T; Makino K; Nakamura H; Yano S; Kuratsu J
    Nihon Rinsho; 2015 May; 73(5):836-43. PubMed ID: 25985640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies.
    Denysenko T; Gennero L; Roos MA; Melcarne A; Juenemann C; Faccani G; Morra I; Cavallo G; Reguzzi S; Pescarmona G; Ponzetto A
    Cell Biochem Funct; 2010 Jul; 28(5):343-51. PubMed ID: 20535838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells.
    Reddy RG; Bhat UA; Chakravarty S; Kumar A
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):165-179. PubMed ID: 32638092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol Through the Modulation of EGFR and CSC Signaling Pathways.
    Doan P; Musa A; Murugesan A; Sipilä V; Candeias NR; Emmert-Streib F; Ruusuvuori P; Granberg K; Yli-Harja O; Kandhavelu M
    Cells; 2020 Mar; 9(3):. PubMed ID: 32164385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the perivascular niche in brain tumors.
    Seano G
    Curr Opin Oncol; 2018 Jan; 30(1):54-60. PubMed ID: 29135607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.
    van den Bossche WBL; Kleijn A; Teunissen CE; Voerman JSA; Teodosio C; Noske DP; van Dongen JJM; Dirven CMF; Lamfers MLM
    Neuro Oncol; 2018 Oct; 20(11):1494-1504. PubMed ID: 29796615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the Treatment of Glioblastoma Multiforme and Cancer Stem Cells with Ordinary Differential Equations.
    Abernathy K; Burke J
    Comput Math Methods Med; 2016; 2016():1239861. PubMed ID: 27022405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.
    Nduom EK; Hadjipanayis CG; Van Meir EG
    Cancer J; 2012; 18(1):100-6. PubMed ID: 22290263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier.
    Da Ros M; De Gregorio V; Iorio AL; Giunti L; Guidi M; de Martino M; Genitori L; Sardi I
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adhering towards tumorigenicity: altered adhesion mechanisms in glioblastoma cancer stem cells.
    Turaga SM; Lathia JD
    CNS Oncol; 2016 Oct; 5(4):251-9. PubMed ID: 27616054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pro-inflammatory modification of cancer cells microsurroundings increases the survival rates for rats with low differentiated malignant glioma of brain.
    Zaitsev S; Sharma HS; Sharma A; Manzhulo I; Polevshchikov A; Kudriavtsev I; Khotimchenko Y; Pak O; Bryukhovetskiy A; Bryukhovetskiy I
    Int Rev Neurobiol; 2020; 151():253-279. PubMed ID: 32448611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy.
    Wang H; Zhou H; Xu J; Lu Y; Ji X; Yao Y; Chao H; Zhang J; Zhang X; Yao S; Wu Y; Wan J
    Cancer Lett; 2021 Jan; 496():134-143. PubMed ID: 33022290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.